| Catalog_no |
ADMC0774 |
| Product_name |
Cariprazine (RGH-188) |
| Category |
抑制剂与激动剂 |
| Size |
10mg/50mg/100mg |
| Price |
2220.00/7220.00/10560.00 |
| Specificity |
Target: Dopamine Receptor. Fields: Cariprazine (RGH-188) is a novel putative antipsychotic drug that exerts partial agonism at dopamine D2/D3 receptors, with preferential binding to D3 receptors, and partial agonism at serotonin 5-HT1A receptors. Ki: |
| Dilution |
Ki: 0.49 nM (D2 receptor), 0.085 nM (D3 receptor), 2.6 nM (5-HT1A receptor)[1] |
| Purification |
99.80% |
| Concentration |
靶点：Dopamine Receptor;IC50：Ki: 0.49 nM (D2 receptor), 0.085 nM (D3 receptor), 2.6 nM (5-HT1A receptor)[1] |
| Storage_stability |
2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| othername |
RGH 188;Cariprazine;RGH188,RGH-188 |
| Molecular Weight |
463.9 |
| Notes |
Cariprazine (RGH-188) is a novel putative antipsychotic drug that exerts partial agonism at dopamine D2/D3 receptors, with preferential binding to D3 receptors, and partial agonism at serotonin 5-HT1A receptors. Ki: 0.49 nM (D2 receptor), 0.085 nM (D |
| Instructions |
 查看与下载 |
